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ABSTRACT: Background: Some patients with FND and FEVD cannot re-establish walking ability with standard
treatment alone.
Cases: Novel invasive treatment of FEVD trialed in three females, aged 19, 30 and 33 years with >18 month history of
FND. None could walk and all were wheelchair-dependent needing home carers. Standard treatment plus novel
step-wise escalation of invasive “intervention+” was individually tailored to correct FEVD; functional electrical
stimulation, botulinum toxin injections, tibial nerve block, serial casting, and for Case 3, manipulation under
anesthetic and surgical tendon lengthening. All regained walking ability and discontinued carers. Case 1 resumed
dancing and Case 3 returned to employment. Improvements were largely maintained at 3 and 6 month follow-up.
Conclusions: As a last resort, invasive adjuncts may be considered in a very small proportion of FND patients who fail
to regain walking ability with standard treatment alone and reach a “dead end” where no further progress is feasible.
Functional Neurological Disorder (FND) affects 16% of patients
referred to neurology outpatient clinics.1 Symptoms can include
sensory, motor and cognitive changes which occur in the
absence of structural nervous system damage.
Sustained abnormal posture and activity can lead to joint
deformity and soft tissue contracture. Fixed equinovarus dystonia
(FEVD) is a musculoskeletal complication which presents a par-
ticular challenge to treat in patients with FND (Fig. 1). FEVD
describes plantar flexion and inversion of the foot and ankle
which is resistant to passive manipulation and in some/severe
cases cannot be corrected. This deformity prevents the patient
from being able to stand, weight-bear or walk thus being wheel-
chair dependent. Correcting FEVD is essential before patients
can embark on a program of gait re-education.
Interventions targeted at the site of symptoms could be con-
sidered counter to recommended treatment models, where the
goal is to retrain movement by diverting attention and focus
from the affected area.2,3 FEVD presents a conundrum as standard
non-invasive treatment may have limited effectiveness at correcting
the sustained abnormal posture which may be associated with soft
tissue and joint changes. We developed a novel approach which
introduced progressively invasive treatments (Intervention+) deliv-
ered in a stepwise manner, supplementing standard treatment for
selected patients with established FEVD. We present three case
studies which may complement consensus opinion by demonstrat-
ing good physical outcomes using this approach.
Case Series
Setting
The Wolfson Neurological Rehabilitation Centre, Queen
Mary’s Hospital, London is a 28-bedded unit providing specialist
1Department of Physiotherapy, Wolfson Neurological Rehabilitation Centre, Queen Mary’s Hospital (part of St George’s Hospitals NHS Foundation Trust) Roehampton
Lane, London, United Kingdom; 2Department of Psychiatry, Wolfson Neurological Rehabilitation Centre, Queen Mary’s Hospital (part of St George’s Hospitals NHS
Foundation Trust) Roehampton Lane, London, United Kingdom
*Correspondence to: Dr. Martine Nadler, Wolfson Neurological Rehabilitation Centre, Queen Mary’s Hospital, Roehampton Lane, London SW15
5PN, UK. E-mail: martine.nadler@stgeorges.nhs.uk
Keywords: FND, FEVD, novel treatment, rehabilitation.
Findings have been presented in abstract form to the British Psychiatry Association Meeting Journal of Neurology Neurosurgery & Psychiatry 90(Suppl
2):A14-A15 May 2019. DOI: 10.1136/jnnp-2019-BNPA.30
Relevant disclosures and conflicts of interest are listed at the end of this article.
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any
medium, provided the original work is properly cited.
Received 5 October 2020; revised 3 May 2021; accepted 20 May 2021.
Published online 00 Month 2021 in Wiley Online Library (wileyonlinelibrary.com). DOI: 10.1002/mdc3.13264
MOVEMENT DISORDERS CLINICAL PRACTICE 2021. doi: 10.1002/mdc3.13264
1
© 2021 The Authors. Movement Disorders Clinical Practice published by Wiley Periodicals LLC. on behalf of International Parkinson and Movement Disorder Society.
CASE SERIES
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neurological in-patient rehabilitation. Fifteen percent of patients
admitted have FND with only three patients presenting with
both, FND and FEVD during the past three years.
Patient Cases 1–3 Overview
Three female patients, Cases 1, 2 and 3, aged 19, 30 and 33 were
diagnosed with FND and FEVD by a neurologist and admitted
for in-patient rehabilitation between September 2017 and March
2019. All were wheelchair-dependent for between 1.5 to
2.5 years and reliant on carers’ support at home, a minimum of
three times daily for personal and domestic activities. They were
heavily reliant on analgesia medication including opioids to man-
age chronic pain symptoms. All gave informed consent to treat-
ment, study publication and inclusion of anonymized
photographs and video recordings.
Intervention
Patients received standard treatment of patient-led, goal oriented,
multidisciplinary approach guided treatment. This is based on the
consensus recommendation to address “illness beliefs, self-
directed attention and abnormal habitual movement patterns
through a process of education, movement retraining and self-
management strategies within a positive and non-judgmental
context.”3
Cases 1, 2 and 3 were unable to progress to gait-re-education as
part of their functional goals using standard treatment and as a last
resort were screened to assess for suitability of “Intervention+”
(Table 1). This is a step-wise program with progressively
more invasive treatment modalities and was discussed fully with the
patient and multidisciplinary team (MDT).
Inclusion Criteria for
Intervention+
1. Patient is fully engaged with therapy program
2. Patient accepts and understands the diagnosis of FND
3. Patient is highly motivated to walk and reduce wheelchair
dependence
4. FEVD physical deformity is not reversible with standard treat-
ment preventing weight-bearing and gait re-education
5. Patient is able to give informed consent for procedures
6. Patient has an on-going rehabilitation goal of being able to
walk which the clinical team believe may be achieved follow-
ing improvement of FEVD
Exclusion Criteria for
Intervention+
1. Identification of significant secondary gain which has been
identified as impacting on rehabilitation e.g. unresolved litiga-
tion, compensation claims or rehousing
2. Psychiatric illness which is impacting on the patient’s health
beliefs, including hypochondriacal disorders and delusional
disorders
3. Acute mental health crisis
4. FEVD is resolving or improving with standard treatment
Treatment Outcomes
All patients had failed to progress with standard treatment and
therefore received different step-wise levels of Intervention+.
Case 1 required functional electrical stimulation (FES) to ankle
muscles and botulinum toxin injections (BoNT) to correct
FEVD. Case 2 demonstrated full ankle range following tibial
nerve block indicating reversibility of FEVD which could not be
achieved with FES and therefore serial casting was used to pro-
vide prolonged stretch to soft tissues (Supplementary Material
S1). Case 3 trialed FES, BoNT, serial casting but FEVD was not
reversible with these interventions. MUA did not change FEVD
position due to severe, fixed, soft tissue contractures and there-
fore surgery was performed (Table 2 and Table S1).
Wheelchair dependence was eliminated and all recovered the
ability to walk (Video 1). Case 1 walked independently without
aids and returned to dance classes (Fig. 2). Case 2 walked with
an aid under supervision, re-established active role as a mother/
homemaker and explored volunteering (Fig. 3). Case 3 walked
independently with an aid and returned to part-time employ-
ment as a personal assistant (Fig. 4). Cases 1 and 3 no longer
needed home carer visits and Case 2 had reduced care needs. All
reported improved independence and quality of life (Table 2). In
addition to physical gains, none required increased pain medica-
tion and Cases 1 and 3 successfully reduced opioid dependence
FIG. 1. Case 3 showing FEVD.
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TABLE 1 Standard treatment and intervention+ selected as appropriate for Cases 1, 2 & 3
Standard treatment
Standard Therapy co-ordinated, consistent approach
from multidisciplinary team








Enable self-management for independence in personal and
domestic activities of daily living
Exercises to improve flexibility, mobility, specific muscle
strengthening
Pacing
Stamina and fitness training
Rhythm distraction techniques
(Gait re-education if effective weight-bearing achieved)
Assessment and treatment of co-morbid psychiatric symptoms
Psychological therapy (behavioral cognitive & empowerment
approaches)
Systemic interventions (family and environment)
Program of rationalizing medication
Pain management
Support self-management and relapse plan
Intervention + (requires psychological and medical screening for suitability)
Order of delivery of Intervention + to address gait re-education
1. Functional electrical stimulation (FES) Applied to tibialis anterior and peronei to address reversible
FEVD position
2. Tibial nerve block (TNB) with Chirocaine/
Levobupivacaine
Selective diagnostic nerve block to temporarily (up to
12 hours) suppress overactivity mainly in soleus,
gastrocnemius, tibialis posterior, flexor digitorum longus
and flexor hallucis longus to assess whether FEVD is
reversible if FES inconclusive
3. Botulinum toxin A injections (BoNT A) using therapeutic
doses to reduce overactivity (not placebo)
Gastrocnemius, soleus, tibialis posterior +/ flexor hallucis
longus/brevis, flexor digitorum longus/brevis
4. Serial casting to ankle joint to correct/maintain improved joint position
5. Manipulation under anesthesia (MUA) Definitive test of correctability of FEVD prior to surgical
intervention.
6. Surgical release of Achilles tendon, tibialis posterior, long
toe flexors
To permanently correct joint position and maintained with
further casting and orthotics
TABLE 2 Stepwise intervention+ delivered to Cases 1, 2 & 3
Case Case 1 Case 2 Case 3
19 year old female dancer 33 year old mother 30 year old female PA
5 year history symptoms 12 year history symptoms 4 year history symptoms
2 year FND diagnosis 18 month FND diagnosis 3 year FND diagnosis
19 week admission 12 week admission 24 week admission
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Six and Twelve Month Follow-Up
None showed recurrence of FEVD at 6 months and all retained
the ability to walk. At 12 months, Case 1 experienced some
recurrence of mild, variable FEVD but this was correctable and
she remained able to walk. Case 2 returned to baseline mobility
levels but due to her improved psychological outlook she
became an active volunteer in an international FND support
group. Case 3 had a recurrence of flexion at the hallux which is
a possible complication shown in stroke patients after
equinovarus surgery.4 She continued to walk and is under regular
orthopedic review.
Discussion
The consensus for managing FEVD is overwhelmingly to use a
non-invasive approach for the majority of FND patients. Invasive
interventions can be detrimental and cause worsening of symp-
toms.3,9 We do not endorse invasive treatments as an obvious
proactive step. However, the carefully selected cases presented
here provide instructive exceptions to this rule as they failed to
regain the ability to walk with non-invasive approaches but
responded to invasive intervention as a last resort. Treatment for
FND varies considerably, depending on symptom presentation
and the center providing treatment.5,6 The standard treatment is
MDT rehabilitation with an emphasis on cognitive behavioral
therapy.7 Clinicians often de-medicalize treatment where possi-
ble, encouraging patients to focus on more “normal” or “natural”
movements and discourage using aids or adaptations as these can
act as maintaining factors for abnormal posture and movement
patterns.8 Unfortunately, access to specialist treatment for patients
with FND often occurs late, and patients present with established
abnormal movement patterns and may have musculoskeletal
contractures, for example in FEVD. In this case series, standard
treatment enabled all the patients to improve their general mus-
cle strength, flexibility, stamina and increased independence in
personal and domestic activities. However, all reached a “pla-
teau” whereby the foot and ankle posture prevented them from
weight-bearing safely and effectively on that side. This precluded
any possibility of their being able to walk again. This case series
suggests that for a very small proportion of patients there may
occasionally be a place for interventions of varying degrees of
invasiveness as a last resort. These should always be discussed
with the patient and carefully introduced in a step-wise progres-
sion to address the FEVD effectively enabling them to overcome
the plateau. It is extremely rare for surgery to be indicated as in
Case 3. Screening was performed by a consultant neuropsychia-
trist to ensure that these patients selected for more invasive pro-
cedures were not suffering from a significant comorbid
psychiatric disorder which could affect or be affected by escalated
medical intervention. All patients were extremely motivated to
walk again and were central to the decision-making process
about any treatment options offered to enable them to work
towards this goal. Suitability screening was carried out to identify
potential to change the physical maladaptation. Reversibility of
FEVD was key in choosing progressively more invasive interven-
tions with surgery deemed appropriate only for Case 3. This was
TABLE 2 Continued








24 hour carer (boyfriend)
Turning aid transfer
Discharge care needs Nil Carer BD Nil
Six month follow up Returned to dancing
No care needs




No recurrence of FEVD
Returned to work
Independent walking with crutches
No care needs
No recurrence of FEVD
Intervention 1 FES FES FES








Intervention 4 Not required Not required Ankle manipulation under anesthetic
Intervention 5 Not required Not required Surgical release of Achilles tendon, tibialis
posterior, long toe flexors
Details of stepwise intervention+ delivered to each Case and outcomes pre- and post-admission and follow-up.
FES, functional electrical stimulation to common peroneal nerve; BoNT, botulinum toxin to posterior tibial muscles; TNB, tibial nerve block; QDS, 4 times/day; TDS, 3
times/day; BD, 2 times.
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discussed with her as manipulation under anesthetic failed to
change her FEVD and she was highly motivated to walk. Since
admission, she improved from being semi-reclined in a wheel-
chair with a custom matrix postural seating system to being able
to hop with crutches but remained unable to weight-bear due to
FEVD on the affected leg.
Some patients with FEVD have a pre-disposing peripheral
injury9 which may be an indicator of poor outcome; our small
cohort did not present with this. They reported pain but none
presented with Chronic Regional Pain Syndrome (CRPS) fea-
tures of allodynia, sudomotor, temperature or color changes.
Allodynia may be an important factor for tolerability of more
invasive interventions such as rigid casting, FES, or BoNT injec-
tions. In general, caution should be exercised when considering
invasive treatment adjuncts as FND symptoms may be
exacerbated.9 Schrag and colleagues reported deterioration of
dystonia in a proportion of these patients following casting.9 To
minimize this risk we ensured that patients understood the ratio-
nale for casting and were keen to proceed, they were given ade-
quate pain relief for the duration of casting and monitored
throughout with the ability to remove cast immediately should
they become unable to tolerate it.
Additional Considerations
Patients with FND and FEVD remain vulnerable to deterio-
ration. Therefore, it is vital that they have access to ongoing
follow-up if rehabilitation gains are to be maintained in this
complex cohort of patients. Surgical intervention is rare for
FND patients with FEVD. This is because there have been
Video 1. Videos of Case 1 and Case 3 to show re-established gait and weightbearing after intervention+.
Video content can be viewed at https://onlinelibrary.wiley.com/doi/10.1002/mdc3.13264
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case reports of patients undergoing surgery for severe pain
resulting from fixed dystonia which has caused these dystonic
postures to present elsewhere in the body.10 In Case 3, the
possibility of this occurring after surgical release of soft-tissue
contracture was explained to her and she gave informed con-
sent to proceed. Carefully timed intensive rehabilitation post-
surgery is of paramount importance together with well-
planned pain relief pre- and post-operatively. The interven-
tion+ approach should be considered only after progress
using standard treatment has plateaued. Careful assessment
and patient selection is essential. Inclusion and exclusion
criteria given above may provide a framework to guide clini-
cal decision making for this novel step-wise intervention+
approach. Additionally, absence of allodynia or pre-existing
peripheral injury may be important indicators for patients
most likely to tolerate intervention+ and re-establish walking
ability. Service considerations include the ability to provide
specialist in-patient care and close monitoring and support by
an MDT experienced with treating patients with FND for as
long as is required. If any of the above considerations are not
addressed then invasive interventions may be unsuccessful or
even detrimental.
FIG. 2. Case 1 (A) pre-treatment and wheelchair dependent, (B) 3 weeks after Botulinum toxin (C) 4 months after Botulinum toxin.
FIG. 3. Case 2 (A) pre-treatment and wheelchair dependent (B) position available immediately after tibial nerve block (C) first cast after
tibial nerve block (D) second cast after tibial nerve block.
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Conclusions
As a last resort, invasive adjuncts may be appropriate in a very
small proportion of FND patients with FEVD who fail to pro-
gress with standard treatment alone and reach a “dead end”
where no further progress is feasible.
It is vital that careful psychological and medical screening is
carried out before considering the intervention+ pathway
described for FEVD in FND patients. If appropriate, this must
only be provided in a specialist, in-patient setting with close
monitoring by the MDT. As a last resort for these three cases
who had stopped responding to standard treatment, the invasive
intervention enabled them to walk again.
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